SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-007493
Filing Date
2022-03-23
Accepted
2022-03-23 07:00:36
Documents
75
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 2377736
2 ex2-3.htm EX-2.3 54657
3 ex12-1.htm EX-12.1 16701
4 ex12-2.htm EX-12.2 16657
5 ex13-1.htm EX-13.1 8157
6 ex15-1.htm EX-15.1 5227
7 form20-f_001.jpg GRAPHIC 32621
8 form20-f_002.jpg GRAPHIC 72546
9 form20-f_003.jpg GRAPHIC 49801
10 image_001.jpg GRAPHIC 1845
  Complete submission text file 0001493152-22-007493.txt   8213315

Data Files

Seq Description Document Type Size
11 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vblt-20211231.xsd EX-101.SCH 46551
12 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vblt-20211231_cal.xml EX-101.CAL 54690
13 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vblt-20211231_def.xml EX-101.DEF 203884
14 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vblt-20211231_lab.xml EX-101.LAB 400904
15 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vblt-20211231_pre.xml EX-101.PRE 302551
69 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 1098805
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 22761553
SIC: 2834 Pharmaceutical Preparations